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Summary Plasma concentrations of certain hormones linked to breast cancer risk were measured in age-
pooled samples from 3,250 rural Chinese women in 65 counties, and 300 British women, all aged 35-64. In
age-groups 35-44, 45-54 and 55-64 respectively, mean oestradiol concentrations were 36% (P = 0.043), 90%
(P<0.001) and 171% (P = 0.001) higher in the British than in the Chinese women, and mean testosterone
concentrations were 48% (P<0.001), 68% (P<0.001) and 53% (P = 0.001) higher in the British than in the
Chinese women. The difference in testosterone concentrations between the two countries appeared to be due
largely to the lower average body weight in the Chinese women. Sex hormone binding globulin did not differ
significantly between the two countries in age groups 35-44 and 45-54, but was 15% (P = 0.002) lower in the
British than in the Chinese women at ages 55-64. Prolactin concentrations did not differ significantly between
the two countries in any age group.
The large international variation in breast cancer rates sug-
gests that it may be possible to reduce the rates in high risk
populations (Doll & Peto, 1981), but the reasons for this
variation are still not fully understood. Breast cancer risk is
clearly related to several reproductive factors (Kelsey, 1979).
Pike et al. (1983) showed that the approximately six-fold
higher rates of breast cancer in the USA than in Japan were
not due to differences in age at first birth, nulliparity or age
at menopause, but that differences in age at menarche and
post-menopausal weight could explain some 70% of the
difference in rates. They suggested that the remaining
difference in breast cancer rates may be due to differences in
hormone levels in the premenopausal period.
The hypothesis that populations with low rates of breast
cancer have low levels of oestrogens (and perhaps of other
hormones) should be easily testable, but the results of
previous studies which compared oestrogen levels in low and
high risk populations have been confusing. In an early study,
MacMahon and his colleagues found lower levels of urinary
oestrone (El) and oestradiol (E2) in premenopausal Oriental
women than in premenopausal Western women (MacMahon
et al., 1974), but differences in such urinary oestrogens are
not necessarily reflected in differences in plasma oestrogens.
Moreover, Hayward et al. (1978) concluded from studies of a
group of women in Tokyo that there were no striking
differences in urinary El or E2 between Japanese and British
premenopausal and post-menopausal women, and they
reported a similar lack- of difference between the plasma
oestrogens of these women. Gray et al. (1982) also found no
differences in plasma oestrogens in their studies of teenage
girls in Japan and the USA. The reason for these discrepan-
cies is not clear, but it is possible that the women and
teenagers studied by the latter groups may no longer have
been characteristic of a low risk population. In a small study,
Goldin et al. (1986) found lower urinary and serum levels of
El and E2 in recent Oriental immigrants to Hawaii. These
investigators paid special attention to ensuring that the
women studied had come from true low-risk populations.
The current study utilised plasma samples from a large
number of rural, non-Westernised Chinese women in 65
counties of China. A previous survey of these counties had
shown that the mean cumulative breast cancer mortality rate
for ages 0-64 in 1973-75 was 3.0 per 1,000 (Li et al., 1981;
Chen et al., 1990), which is much less than the comparable
figure for England and Wales of 19.0 per 1,000 in 1975
(Office of Population Censuses and Surveys, 1977). The
hypothesis tested was that plasma concentrations of E2, and
of other hormones possibly related to breast cancer, would
be lower in the low risk Chinese women than in British
women.
Methods
Subjects: China
The selection of normal subjects and collection of blood in
China are described in detail in the monograph by Chen et
al. (1990). Briefly, 65 rural counties throughout China were
chosen to represent a wide range of mortality rates from
seven of the most common cancers: cancers of the
nasopharynx, oesophagus, stomach, liver, colorectum, lung
and leukaemia. Two communes were chosen at random
within each county, and, within each commune, 25 women
aged 35-64 (with approximately equal numbers in each 10-
year age group) were studied between September and
December 1983. Blood was drawn into heparinised vacu-
tainers between 06.00 and 12.00 h. Plasma samples were
separated and mixed with sodium ascorbate (5 mgml-') then
stored at - 15°C to -20C for up to two months before
being transported to Beijing, where they were thawed and
pooled into three pools per commune according to age
(35-44, 45-54, 55-64). The total number of pools was
therefore 390 (3 age groups x 2 communes x 65 counties).
Samples were stored in Beijing at - 30°C for up to six
months. Samples were then transported to Cornell Univer-
sity, Ithaca, New York, and divided into smaller volumes for
storage at - 80°C for three years, then sent to the Imperial
Cancer Research Fund's laboratory for assay in September
1986.
The survey in China collected data on age, height, weight
and reproductive history from each woman. Information was
not recorded on whether a woman was pregnant or lactating
at the time of plasma collection, but the instructions to the
field teams were to exclude pregnant or lactating women
from the study. Information on contraceptive practices was
not collected, but oral contraceptives are rarely used in rural
areas of China and injectable contraceptives are not
available, the most common contraceptive method being the
intrauterine device (J. Chen, personal communication).
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Subjects: Britain
The samples used as a British comparison group were taken
from a bank of frozen sera collected during a prospective
study of breast cancer in Guernsey (see Moore et al., 1986).
Samples were collected between 10.15 and 20.25 h (median
16.00 h), between 1978 and 1984, and stored at - 20°C.
Three hundred serum samples were selected from subjects
aged 35-64 (100 in each 10-year age group) who had never
used exogenous sex hormones and who had had at least one
full-term pregnancy. No women were pregnant or lactating at
the time of serum collection. Selection was not truly random,
but was determined by the accessibility and sufficiency of
samples. Samples in each age group were arbitrarily divided
into 10 groups of 10 and pools of serum made and refrozen.
The total number of pools was therefore 30 (3 age
groups x 10 arbitrary groups).
Table I shows the mean values for age, body size and
reproductive variables. The Chinese women in the 35-44 age
group were on average 0.8 years younger than the British
women and in all age groups the study women in China were
shorter, lighter, older at menarche and of higher parity than
the British women. The data collected relating to first preg-
nancy differed in the two countries, the Chinese survey recor-
ding age at first pregnancy and the British survey recording
age at first birth. The lower values in China than Britain
therefore exaggerate the difference between the countries in
age at first birth. For women aged 55-64, the average age at
menopause was 1.8 years younger in the Chinese than the
British women.
Assays
All measurements on British samples (30 pools) were made in
duplicate, but due to the small volume of the Chinese plasma
samples (0.5 ml, 390 pools) only single measurements were
made on each sample, and for some pools there was insu-
fficient plasma to measure all the hormones. In each assay
batch most of the samples were Chinese, with the British
samples spread approximately equally between batches.
E2 was measured with a non-extraction coated tube
radioimmunoassay kit (Diagnostic Products Corporation,
Los Angeles, USA). Intra- and inter-assay coefficients of
variation were 13.1% and 8.8% respectively at a concen-
tration of 556 pmol 1'. Values below the lowest E2 standard
(70 pmol 1`) were estimated by extrapolation of the standard
curve. For two Chinese communes, the E2 concentration in
Table I Comparison of mean age, height, weight and reproductive
variables in study women in China and Britain
Variable" Age (years) China Britain p
Age 35-44 38.9 39.7 0.007
Age 45-54 49.6 49.3 0.246
Age 55-64 59.1 59.0 0.894
Height 35-44 155 161 <0.001
Height 45-54 153 160 <0.001
Height 55-64 152 158 <0.001
Weight 35-44 50.1 63.6 <0.001
Weight 45-54 48.5 65.0 <0.001
Weight 55-64 46.7 65.6 <0.001
Menarche 35-44 17.1 13.1 <0.001
Menarche 45-54 16.9 13.3 <0.001
Menarche 55-64 16.9 13.1 <0.001
Fpb 35-44 22.2 23.9 0.002
FP 45-54 21.8 24.5 <0.001
FP 55-64 22.1 26.1 <0.001
Parity 35-44 3.7 2.4 <0.001
Parity 45-54 4.9 2.5 <0.001
Parity 55-64 4.7 2.5 <0.001
Menopause 55-64 48.1 49.9 0.007
'Age, menarche, first pregnancy and menopause in years; height in
cm; weight in kg. bFirst pregnancy. The figures for China are for age at
first pregnancy in parous women (98.1% of the Chinese women were
parous). The figures for Britain are for age at first birth (all the British
women were parous).
the pool of plasma from women aged 35-44 was indistin-
guishable from zero, and since values this low do not occur
in premenopausal women (unless they are using contraceptive
steroids) it was decided that these results were unacceptable.
These results were therefore rejected, and the other hormone
measurements for this age group in the two communes con-
cerned were also rejected. Testosterone (T) was measured
with a non-extraction double antibody radioimmunoassay kit
(RIA (UK) Ltd, Washington, UK). Intra- and inter-assay
coefficients of variation were 5.6% and 6.1% respectively at a
concentration of 1.46nmoll['. Sex hormone binding glob-
ulin (SHBG) was measured with an immunoradiometric
assay kit (Farmos Diagnostica, Oulunsalo, Finland). Intra-
and inter-assay coefficients of variation were 3.1% and 6.1%
respectively at a concentration of 65.4 nmol 1-. Prolactin
(HPr) was measured with a double antibody radioimmunoas-
say kit (Amersham International, Amersham, UK). Intra-
and inter-assay coefficients of variation were 6.8% and 9.9%
respectively at a concentration of 346 pmol 1-'.
The Chinese samples were of heparinised plasma, the
British samples were of serum. There is no reason to suppose
that this difference would cause more than a very small
difference in the results. The E2 kit protocol presents data
showing that heparinised plasma yields virtually the same
results as serum (mean of 15 samples 354 pmol 1- for serum
and 355 pmol 1i for heparinised plasma). The T, SHBG and
HPr kit protocols recommend the use of serum or plasma
without distinction.
Statistics
All hormone concentrations were measured in pooled sam-
ples and are an estimate of the arithmetic means of the
individual samples in each pool, therefore no transformations
were used in the statistical analysis. The Chinese hormone
values used in the analysis were the means in each age group
of the values for the two communes in each county. Com-
parisons between the countries were made using unpaired t
tests. Repeating these comparisons with t tests weighted ac-
cording to the number of women in each pool did not affect
the results, therefore the results of the unweighted tests are
presented. Two-sided P values are quoted.
Results
In both countries mean E2 concentrations decreased from the
35-44 age group to the 55-64 age group, with intermediate
values in the 45-54 group (Table II and Figure 1). In all
three age groups E2 concentrations were significantly higher
in the British than in the Chinese women (by 36%, 90% and
171% respectively in successive age groups).
The results for T were similar to those for E2, with a
decrease in both countries with increasing age but
significantly higher concentrations in the British women (by
48%, 68% and 53% respectively in successive age groups)
(Table II). One Chinese county had a high T value
(4.3nmoll1') in the 35-44 age group. The other hormone
values for this pool were well within the normal female
range, and no explanation could be found for this outlier. T
was significantly positively correlated with body weight
among the Chinese women (Pearson correlation coefficients
were 0.24, 0.32 and 0.48 in successive age groups), and
examination of scatterplots of T with weight suggested that
much of the difference in mean values between the countries
may be due to the difference in body weight (Figure 2).
The mean values for SHBG did not differ significantly
between the two countries except in the 55-64 (post-
menopausal) age group, where the mean value was 17% to
20% less than that at earlier ages in the British women, but
only 4% less in the Chinese women (Table II).
HPr decreased with age in both countries, but did not
differ significantly between the two countries, although the
mean value for the 35-44 age group was 26% higher in the
British women than in the Chinese women (Table II).SEX HORMONES IN CHINA AND BRITAIN 633
Table II Comparison ofmean hormone concentrations in study women in China and
Britain
China Britain
Variable' Age (years) Hormone conc. Nb Hormone conc. N p
E2 35-44 304 62 413 10 0.043
E2 45-54 147 63 280 10 <0.001
E2 55-64 21 63 57 10 0.001
T 35-44 1.28 59 1.89 10 <0.001
T 45-54 0.96 60 1.61 10 <0.001
T 55-64 0.94 57 1.44 10 0.001
SHBG 35-44 74 '62 72 10 0.651
SHBG 45-54 74 63 75 10 0.796
SHBG 55-64 71 63 60 10 0.002
HPr 35-44 340 58 428 10 0.068
HPr 45-54 273 63 274 10 0.976
HPr 55-64 225 62 234 10 0.782
0E2 = oestradiol, pmol 1'; T = testosterone, nmol 1-'; SHBG = sex hormone binding
globulin, nmol 1 '; HPr = prolactin, pmol 1- . bFortheChinese samples, Nis the number
ofcounties for which measurements were made. For the British samples, Nis the number
ofpools of serum.
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Figure 1 Oestradiol (E2) concentrations in rural Chinese women and in British women.
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Figure 2 Relationship of testosterone (T) with weight in rural Chinese women (C) and in British women (B).
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Discussion
The advantages of this study are that measurements were
made on samples from a very large number of women, and
that the Chinese women were living in a traditional way and
were representative of a population at very low risk of breast
cancer. The study also has some disadvantages because of the
different methods used for sample collection and processing
in the two countries. We do not think that these differences
would have a large effect on the assays, but it is not feasible
to test this assumption properly without repeating the whole
study. It is therefore necessary to interpret the comparisons
between the two countries with some caution. The Chinese
samples were collected earlier in the day than the British
samples, and in September to December rather than all year
round. E2 concentrations in premenopausal women fluctuate
during the day, and mean concentrations may be about 20%
higher in the morning than in the afternoon (Lenton et al.,
1978), so the Chinese E2 results for ages 35-44 may be
biased upwards a little in comparison with the British results.
Vermeulen (1976) reported that E2 does not vary consistently
during the day in post-menopausal women, but that plasma
T is about 25% higher in the morning and afternoon than in
the evening, so the Chinese T results may be biased upwards
a little in comparison with the British T results. SHBG falls
during the night (Moore & Bulbrook, 1988) but does not
vary significantly between morning and early evening (Key et
al., 1990). HPr is high during the night and falls after waking
(Gray et al., 1981), but rises a little during the afternoon and
early evening (Wang et al., 1984), so that the direction of any
bias between countries in our results for HPr is not clear. In
a study in Finland (which is much further north than China),
Kauppila et al. (1987) found that mean E2 and T concentra-
tions in premenopausal women were 13% and 12% lower
respectively during the darkest months (November to
January) than during the lightest months (May to June), so it
is possible that the Chinese samples in the current study are a
slight underestimate of year-round E2 and T. Kauppila et al.
(1987) found that seasonal changes in mean SHBG and HPr
concentrations were negligible.
The samples were pooled according to age rather than
menopausal status. The pools for ages 45-54 therefore repre-
sent a mixture of premenopausal and post-menopausal
women, and the lower E2 level in China than Britain for this
age group is partly due to the earlier menopause of the
Chinese women. The E2 values for ages 35-44 and 55-64,
however, show that mean plasma E2 in both premenopausal
and post-menopausal women is lower in rural Chinese
women than in British women.
The results of previous studies of oestrogens in
premenopausal and post-menopausal Oriental women (living
in their homeland or recently immigrant) and Western
women are summarised in Table III. Except for the study of
Gray et al. (1982), the studies have found lower oestrogen
levels in premenopausal Oriental women. The differences
reported by Hayward et al. (1978) are likely to be underes-
timates because the Japanese samples were collected on
averge 3 days later in the cycle, and therefore probably closer
to the luteal phase peak of E2 (Bulbrook et al., 1976).
In premenopausal women most E2 is produced by the
ovaries and there is no clear relationship between weight and
E2, at least within the normal weight range (Zumoff et al.,
1981). Rose et al. (1987a) found that a reduction in the
percentage of energy from fat from 35% to 21% for 3
months in premenopausal women caused a decrease in serum
E2 concentration. The mean percentage of energy from fat in
the Chinese counties surveyed was 15.0% (range 5.9-45.2%),
much lower than the mean percentage of energy from fat in
Britain in 1980 of 42.6% (Ministry of Agriculture, Fisheries
and Food, 1982). It is possible that the lower E2 of the
Chinese women aged 35-44 is due to their low fat diet, but
the difference might also be due to other dietary constituents,
or to differences in exercise or in other aspects of lifestyle.
The Japanese teenagers studied by Gray et al. (1982) almost
certainly had a low fat intake (probably 20-25% of energy
from fat), but this did not produce low oestrogen levels.
The other recent studies of post-menopausal Oriental
women have found lower oestrogen levels than those in
Western women (Table III), but the earlier study of Hayward
et al. (1978) found no evidence of this. We cannot explain
this discrepancy, other than to suggest that it might be
related to the relative affluence of the Japanese subjects in
that study.
In post-menopausal women E2 is derived largely from
adrenally secreted androstenedione (Judd et al., 1982), and
most studies have found that plasma concentrations of E2
are positively correlated with body weight (Davidson et al.,
1981; Begg et al., 1987). Although significant correlations
between weight and E2 were not found in this age group
within China or Britain (data not shown), this was probably
due to the poor assay precision in this E2 range, and it is
likely that at least part of the difference in E2 in this age
group is due to the large difference in body weight between
countries. However, the 171% increase in mean E2 for a
40% increase in mean weight is larger than would be
expected; for example the results of Davidson et al. (1981)
would predict only an approximately 50% increase in E2 in
the British women. It appears, therefore, that another factor
or factors must be involved, such as a direct effect of a
low-fat diet (Boyar et al., 1988; Prentice et al., 1990).
The Chinese women had, on average, later menarche, ear-
lier first birth, higher parity and earlier menopause than the
British women, and all of these factors would produce lower
breast cancer mortality in the Chinese. The differences
between the Chinese and British women in mean E2 concen-
trations are consistent with an oestrogen hypothesis for
breast cancer, and are large enough when taken in conjunc-
tion with the other risk factor differences to explain the
whole of the difference in breast cancer rates (Pike et al.,
1983; Pike, 1990). It is possible that age at menarche and
parity are themselves related to breast cancer risk partly
through a relationship with long-term changes in hormone
levels (Trichopoulos et al., 1980; Bernstein et al., 1985; Apter
et al., 1989), but they may also be related to breast cancer
risk through other mechanisms (e.g. the possible effect of
pregnancy on breast cell differentiation).
The lower T of the Chinese women in this study is consis-
tent with the results of previous studies of Oriental women
(Hill et al., 1985; Goldin et al., 1986). The data suggest that
the lower T of the Chinese women may be largely due to
their lower weight. This conclusion is compatible with the
positive correlation between T and body weight reported in
some other studies (Kopelman et al., 1980; Bates & Whit-
worth, 1982; Wild et al., 1983), although not in all
(Vermeulen & Verdonck, 1978; Adami et al., 1979).
The current study showed very similar SHBG concentra-
tions in women aged 35 to 54 in China and Britain, in
agreement with previous studies of premenopausal Oriental
women (Moore et al., 1983; Bernstein et al., 1990). In the
55-64 age group, however, the Chinese had higher values
than the British. The post-menopausal decrease in SHBG in
British women was shown clearly in a previous analysis of
samples from 1221 women in the Guernsey cohort (Moore et
al., 1987). The absence of this effect in the Chinese women
might be related to their low body weight or to their low T
levels. Previous studies of post-menopausal women have not
found significantly higher SHBG in Oriental women than in
Western women, but the Oriental women in those studies
were heavier than those in the current study (Moore et al.,
1983; Shimizu et al., 1990). The similarity between SHBG
levels in Chinese and British women aged 35-54 is interest-
ing, because of the large difference in mean body weight
between the two countries and the inverse correlation
between SHBG and weight within both countries: a similar
phenomenon was noted in a comparison of SHBG and
weight in British and Egyptian women (Anglo-Egyptian
Health Agreement Collaborative Study, 1988).
Previous studies have found no difference in HPr between
Oriental and Western women (Hayward et al., 1978; Gray et
al., 1982). The current results support this conclusion, butSEX HORMONES IN CHINA AND BRITAIN 635
Table III Previous studies which havecompared oestrogen levels inOriental women andWestern women: results areexpressed as the mean level in
Oriental women as a percentage of the mean level in Western women
PremenopausaP Post-menopausal
Urine Serum/plasma Urine Serwn/plasma
Oriental Day of
Reference subjects Nb cycle Elt E2d El E2 N Weighte El E2 El E2
MacMahon et al., 1974 Orientals,
Hong Kong,
Taipei 89/191 10 51 51 - - - - - - - -
and Japan 89/191 21 54 54 - - - - - - - -
Hayward et al., 1978 Japanese,
Japan 29/24 16-24f 89 66 72 78 30/29 84 115 117 95 112
Gray et al., 1982 Japanese,
Japan 50/50 11 81 85 91 97 - - - - - -
Goldin et al., 1986 Orientals,
recently
arrived in
Hawaii 10/12 Midfollg 43 39 75 56 10/8 87 32 29 93 30
Bernstein et al., 1990 Chinese,
China 42/39 22 - - - 83 - - - - - -
Shimizu et al., 1990 Japanese,
Japan - - - - - - 38/91 88 - - 68 73
Current study Chinese,
China 100/1080 Any - - - 74 100/1080 71 - - - 37
"Where thepapergives results formore than one premenopausal age-group, the figures given arecalculated from the arithmeticmean ofthe values
for ages 20 and above in the separate age groups. bNumber of Western women/number of Oriental women. cOestrone. "Oestradiol. eWeight is
expressed as the mean weight in Oriental women as a percentage of the mean weight in Western women. fUrine was collected during days 2-5
following the day ofblood collection. sMidfollicular. Plasma was collected on threeconsecutive days, urineover 72 h, both repeated after 6months.
some caution should be maintained because bioassays may
provide a better measure of HPr than do current radioim-
munoassay methods (Rose et al., 1987b). HPr declines with
increasing parity (Yu et al., 1981; Wang et al., 1984), but the
effect is small beyond three births (Wang et al., 1987), so the
difference in parity between the Chinese and British women
in the current study would not have been expected to have a
large effect on HPr.
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